From Gluten Free Watchdog, LLC:
Great news on the allergen labeling front: the ADINA Act (H.R. 3821) was reintroduced into the 19th Congress on Friday, June 6, 2025 by U.S. Representative Kelly Morrison (MN-03).
The ADINA Act is co-led by Representatives Mike Lawler (NY-17), Doris Matsui (CA-07), and Ben Cline (VA-06).
⭐️ This bill would amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain. ⭐️
Because this bill was again reintroduced with bipartisan support in the House, we are hopeful that it gains traction.
🙏🏻 Please consider reaching out to your U.S. Representatives to ask them to co-sponsor H.R. 3821.
You can do this by contacting Daniela Puente (Daniela.Puente@mail.house.gov), Senior Health Legislative Assistant to Rep. Morrison and the primary contact for the Adina Act on Capitol Hill. To read the press release for this bill, see https://morrison.house.gov/media/press-releases/us-rep-kelly-morrison-introduces-bipartisan-bill-improve-allergen-safety. To read the bill, see https://morrison.house.gov/sites/evo-subsites/morrison.house.gov/files/evo-media-document/adina-act-119th-bill-text.pdf
","author_name":"Andrea Tucker"}